Evidence map›Paper›PMID 40212986›Full record

ReviewF1000Research2025

Trends, key contributors, and emerging issues in honey and breast cancer: A bibliometric analysis from 2014 to 2024.

Andi Nilawati Usman, Fendi Fendi, Zafitri Nulandari, Dinah Inrawati Agustin

Abstract readReview
In one paragraph

Review in F1000Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andi Nilawati UsmanDepartment of Midwifery, Graduate School, Hasanuddin University, Makassar, South Sulawesi, 90245, Indonesia.ORCID 0000-0002-1136-1704
Fendi FendiResearch Institute and Community Service, Wuna Agricultural Sciences University, Muna, Southeast Sulawesi, 93654, Indonesia.
Zafitri NulandariDepartment of Midwifery, Graduate School, Hasanuddin University, Makassar, South Sulawesi, 90245, Indonesia.
Dinah Inrawati AgustinDepartment of Midwifery, Graduate School, Hasanuddin University, Makassar, South Sulawesi, 90245, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Honey, a natural product with diverse bioactive compounds, has been increasingly explored for its potential anticancer properties. This study aims to comprehensively analyze the scientific literature on the relationship between honey and breast cancer. Methods: A bibliometric analysis was conducted using the ScienceDirect database to identify publications from 2014 to 2024. Data on publication trends, author collaboration, and keyword analysis were extracted to gain insight into the research landscape. Keyword analysis identified nine distinct clusters, indicating diverse research directions regarding the role of honey in breast cancer treatment. Results: In Key journals such as the Journal of Ethnopharmacology and Food Chemistry have been at the forefront of disseminating research findings in this domain, demonstrating a strongly interdisciplinary approach that bridges traditional medicine and modern scientific inquiry. The increasing interest in the anticancer properties of honey, as evidenced by the growing number of studies, underlines its potential as a promising natural agent for breast cancer prevention and treatment. Conclusions: This study provides a comprehensive overview of the current knowledge landscape and highlights emerging issues that require further exploration.

Indexed as

BibliometricsBreast NeoplasmsHoneyAntineoplastic AgentsFemaleHumansAntineoplastic Agentsbibliometric analysisbreast cancerhoneyScienceDirectVOSviewer

Identifiers

PMID40212986
PMCPMC11983675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.